Harrison.ai vs Aidoc vs Lunit vs Qure.ai
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Harrison.ai
Australian AI that reads 124+ chest X-ray findings in under a minute
Visit
|
Aidoc
Always-on clinical AI that triages CT findings — ICH, PE, spinal fract...
Visit
|
Lunit
KOSDAQ-listed Korean AI for breast and lung cancer screening
Visit
|
|
|
|---|---|---|---|---|
| RECATOOLS Score | 8.2 / 10 | 8.2 / 10 | 6.7 / 10 | 8.2 / 10 |
| Capability | ||||
| Value for money | ||||
| Ease of use | ||||
| ASEAN readiness | ||||
| API quality | ||||
| Pricing | Enterprise | Enterprise | Enterprise | Enterprise |
| Free tier | Harrison.Rad 1.5 available free for research at chat.harrison.ai | No free tier; demo available on request | — | No free tier; enterprise contracts only; trial demos available via sales |
| Paid from | Enterprise SaaS contracts; Open Platform charges for compute and support only | Custom enterprise pricing; contact sales for per-site or per-volume quotes | — | Custom enterprise pricing; contact sales for per-scan or site-licence quotes |
| Has API | ✓ | ✓ | ✗ | ✓ |
| Open source | ✗ | ✗ | ✗ | ✗ |
| Free to use | ✗ | ✗ | ✗ | ✗ |
| Users | 3,400+ clinicians at 1,000+ sites across 40+ countries | nearly 2,000 hospitals worldwide; 150+ US health systems; 60M+ cases/year | — | 34M+ lives impacted across 4,800+ clinical sites in 105+ countries (as of late 2025) |
| Founded | 2018 | 2016 | 2013 | 2016 |
| Maker | Harrison.ai (independent; Sonic Healthcare holds 18% stake via Franklin.ai JV) | Aidoc Medical Ltd. | — | Independent (Series D — Lightspeed, 360 ONE Asset, Merck GHI Fund) |
| Verdict | Harrison.ai is one of the most clinically validated medical imaging AI platforms globally, backed by peer-reviewed publications in The Lancet Digital Health and European Radiology, 12 FDA clearances, three FDA Breakthrou... |
Aidoc leads the FDA-cleared radiology AI market by clearance count and clinical breadth. Its CARE foundation model — the first cleared for 14 simultaneous abdominal CT indications — is a real step beyond single-condition... |
Lunit is the most clinically validated medical-AI company to come out of Korea, and one of the few in the category with real revenue rather than just pilot deployments — Q1 2026 revenue hit 24 billion won, up nearly 25%... |
Qure.ai is one of the most credentialled and widely deployed AI radiology platforms in the world, with a regulatory portfolio (26 FDA-cleared indications, Class IIb CE under EU MDR, CDSCO Class B in India, registrations... |
| Full review → | Full review → | Full review → | Full review → |
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.